Related Experiment Video
Updated: Apr 15, 2026
10:28
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
10.4K
Ledipasvir/Sofosbuvir (harvoni): improving options for hepatitis C virus infection
P & T : a Peer-Reviewed Journal for Formulary Management
|April 11, 2015
Summary
Ledipasvir/sofosbuvir, known as Harvoni, offers improved treatment options for hepatitis C virus infection. This combination therapy represents a significant advancement in managing this chronic liver disease.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Hepatitis C virus (HCV) infection is a major global health concern.
- Current treatment options for HCV have limitations in efficacy and tolerability.
- The development of direct-acting antivirals (DAAs) has revolutionized HCV management.
Purpose of the Study:
- To evaluate the efficacy and safety of ledipasvir/sofosbuvir (Harvoni) for treating hepatitis C virus infection.
- To assess the impact of this new therapeutic option on patient outcomes.
- To compare ledipasvir/sofosbuvir with existing treatment regimens.
Main Methods:
- Clinical trials involving patients with chronic hepatitis C.
- Administration of ledipasvir/sofosbuvir (Harvoni) therapy.
- Monitoring of viral load, liver function, and adverse events.
Main Results:
- High sustained virologic response (SVR) rates observed with ledipasvir/sofosbuvir.
- Favorable safety profile with minimal side effects.
- Improved treatment adherence and completion rates.
Conclusions:
- Ledipasvir/sofosbuvir (Harvoni) is a highly effective and well-tolerated treatment for hepatitis C virus infection.
- This regimen offers a significant improvement over previous therapies.
- It represents a crucial advancement in the global effort to eliminate HCV.
Related Concept Videos
01:25Hepatitis
61
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
61
01:30Inhibitors of Viral Protein Synthesis
35
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
35
01:10Retrovirus Life Cycles
50.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.8K
01:29Viruses with RNA Genomes
1.4K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.4K
01:24Cystic Fibrosis: Management
637
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
637
02:33Retroviruses
16.1K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
16.1K